ILIM
EXAS

Irish Life Investment Managers’s Exact Sciences EXAS Stock Holding History

Irish Life Investment Managers’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$43.5K Buy
+3,132
New +$34K ﹤0.01% 1510

Other funds holding EXAS

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Irish Life Investment Managers's EXAS Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in Exact Sciences (EXAS) in Q2 2013: 3,132 shares worth $43.5K. The stake represents ﹤0.01% of the portfolio and ranks #1510 among its holdings.

121 funds tracked by Wall St. Rank hold EXAS as of Q2 2013.

  • Irish Life Investment Managers held 3,132 shares of Exact Sciences worth $43.5K as of Q2 2013.
  • Exact Sciences was a new Irish Life Investment Managers position in Q2 2013.
  • Exact Sciences made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1510 holding.
  • 121 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.